U.S. federal trademark · Serial No. 98077157
Pharmaceutical preparations for targeting nucleophilic amino acid residues in proteins involved in human diseases, namely, cancer and for the treatment of human diseases, namely, cancer
Research and development in the field of covalent inhibitors targeting nucleophilic amino acid residues in proteins involved in human diseases, namely, cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.